To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Autologous PRP & dextrose prolotherapy equally effective in recalcitrant plantar fasciitis

Download
Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Author Verified
Ace Report Cover
September 2014

Autologous PRP & dextrose prolotherapy equally effective in recalcitrant plantar fasciitis

Vol: 3| Issue: 9| Number:66| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A

Autologous platelet-rich plasma versus dextrose prolotherapy for the treatment of chronic recalcitrant plantar fasciitis

PM R. 2014 Feb;6(2):152-8. doi: 10.1016/j.pmrj.2013.07.003.

Contributing Authors:
E Kim JH Lee

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

21 patients diagnosed with chronic recalcitrant plantar fasciitis were randomized to receive either dextrose prolotherapy (DP) or autologous platelet-rich plasma (PRP) injection therapy. The purpose was to evaluate the efficacies of these treatments and additionally, to assess whether one is more effective. Results at 28 weeks indicated that both treatments significantly improved total Foot Functi...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue